Cognizant Investments increased by 1.8% to $113.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.2%, from $94.00M to $113.00M. Over 5 years (FY 2020 to FY 2025), Investments shows a downward trend with a -24.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in this area suggests the company is deploying excess capital into long-term wealth-generating assets.
These are investments in securities, joint ventures, or other long-term financial assets that the company intends to hol...
Common in large, diversified healthcare firms that manage significant investment portfolios.
non_current_assets_long_term_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $433.00M | $466.00M | $463.00M | $458.00M | $443.00M | $431.00M | $427.00M | $424.00M | $425.00M | $432.00M | $435.00M | $83.00M | $86.00M | $90.00M | $90.00M | $94.00M | $110.00M | $107.00M | $111.00M | $113.00M |
| QoQ Change | — | +7.6% | -0.6% | -1.1% | -3.3% | -2.7% | -0.9% | -0.7% | +0.2% | +1.6% | +0.7% | -80.9% | +3.6% | +4.7% | +0.0% | +4.4% | +17.0% | -2.7% | +3.7% | +1.8% |
| YoY Change | — | — | — | — | +2.3% | -7.5% | -7.8% | -7.4% | -4.1% | +0.2% | +1.9% | -80.4% | -79.8% | -79.2% | -79.3% | +13.3% | +27.9% | +18.9% | +23.3% | +20.2% |